EKF Diagnostics (LON:EKF) Stock Price Down 7% – Time to Sell?

Shares of EKF Diagnostics Holdings plc (LON:EKF) were down 7% during trading on Saturday . The stock traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). Approximately 2,281,890 shares changed hands during trading, an increase of 404% from the average daily volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Trading Down 7.0%

The company has a market cap of £116.76 million, a price-to-earnings ratio of 19.26 and a beta of 0.57. The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34. The firm’s 50-day moving average price is GBX 29.18 and its 200 day moving average price is GBX 26.59.

EKF Diagnostics (LON:EKF) last announced its quarterly earnings data on Tuesday, September 16th. The company reported GBX 0.43 EPS for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. As a group, equities analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on:

? Point-of-Care analysers in the key areas of Hematology and Diabetes

? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.